Trials / Completed
CompletedNCT01762982
Patch Test of Benzalkonium Chloride Disinfectant Spray
A Single Centre, Examiner-blind Human Patch Test of Bactroban Disinfectant Liquid on Normal Skin
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to evaluate the irritation potential of benzalkonium chloride disinfectant spray when placed in contact with normal human skin.
Detailed description
Benzalkonium chloride is recognized as safe and effective for short term use as first aid antiseptic drug products. In this study, benzalkonium chloride disinfectant spray will be compared to a positive control, and two negative control for irritancy potential on normal skin according to Chinese Patch Test Guideline (China Health Authority 2002). The skin irritation assessment will characterize the test products individually in terms of symptomatology using a 5-point categorical scale ranging from 0 (no visible reaction) to 4 (Erythema,edema˛ extreme blistering).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.13% Benzalkonium Chloride | Finn Chamber filled with benzalkonium chloride (0.13%) disinfectant spray water solution |
| DRUG | SLS Solution | Finn Chamber filled with SLS (0.3% w/v) water solution |
| DRUG | Normal Saline Water | Finn Chamber filled with Normal Saline water (0.9% w/v) |
| OTHER | Empty Finn Chamber | Empty Finn Chamber |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2013-01-08
- Last updated
- 2014-01-22
- Results posted
- 2014-01-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01762982. Inclusion in this directory is not an endorsement.